 | This article contains promotional content. (August 2021) |
 | |
 Co-headquarters and laboratory complex, Silver Spring, Maryland (above), co-headquarters, Research Triangle Park, North Carolina (below) | |
| Company type | Public |
|---|---|
| Industry | Biotechnology |
| Founded | 1996 |
| Headquarters | , United States |
| Revenue |  $2.33 Billion (2023)[1] |
Number of employees | 1,168 |
| Website | unither |
United Therapeutics Corporation is an American publicly traded biotechnology company[2] and public benefit corporation[3] listed on the NASDAQ under the symbol UTHR.[4][5] It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.[6]
- ^ "U.S. Securities and Exchange Commission".
- ^ "United Therapeutics (UTHR)". Forbes.
- ^ "United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval". PRNewswire.
- ^ "United Therapeutics Corporation (UTHR) stock price, news, quote & history – Yahoo Finance". uk.finance.yahoo.com.
- ^ "Commit To Buy United Therapeutics At $105, Earn 9% Annualized Using Options". Forbes. September 25, 2014.
- ^ United Therapeutics Corp. "Locations." Accessed October 4, 2020.